Cancer Therapy: Toward Precision Medicine: A Cancer Molecular Subtyping Nano‐Strategy for RNA Biomarkers in Tumor and Urine (Small 45/2016)
Source abstract
Abstract
Cancer is a heterogeneous disease manifesting as a variety of intricate subtypes that require different treatment strategies. On page 6233, E. J. H. Wee, Y. Wang, M. Trau, and co-workers present a rapid multiplexed detection platform for cancer molecular subtyping based on a patient's unique RNA biomarker profile. This platform could allow for effective personalized cancer treatments (i.e. precision medicine).
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gene expression and cancer classification · Molecular Biology Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Centre for Personalized Nanomedicine Australian Institute for Bioengineering and Nanotechnology (AIBN) The University of Queensland QLD 4072 Australia
School of Chemistry and Molecular Biosciences The University of Queensland QLD 4072 Australia
References
Reference metadata was not supplied for this record.